Annual Meeting of the MOLOGEN AG

On this year’s Annual Meeting of the MOLOGEN AG on June 7, 2006, in Berlin the company welcomed about 190 shareholders and visitors. Therewith the event attracted much more attention this year than the years before.

The presence was 28.88% of the registered capital; this means that the attendant shareholders represented about 2.4 million votes. All resolutions of the administration passed the Annual Meeting with a high acceptance ranging between 96% and 99% of the votes. The representative of an association of small shareholders filed an objection against the agenda item no. 8 (authorization to issue convertible bonds).

About MOLOGEN

MOLOGEN uses its proprietary DNA technologies to create and develop treatments for high-unmet-need illnesses. The main focuses are the unique and patented MIDGE and dSLIM technologies. Based on these platforms, MOLOGEN is developing DNA-based vaccines and therapeutics to prevent or cure a wide range of diseases.

Going public in 1998, MOLOGEN was one of the first German biotechnology companies to be floated on the stock exchange. The MOLOGEN shares are traded on the Geregelter Markt in Frankfurt.

Disclaimer concerning prognoses

Certain statements in this communication contain formulations or terms referring to the future or future developments, as well as negations of such formulations or terms, or similar terminology. These are described as forward-looking statements. In addition, all information in this communication regarding planned or future results of business segments, financial classification numbers, developments of the financial situation, or other financial or statistical data contains such forward-looking statements. The company cautions prospective investors not to rely on such forward-looking statements as certain prognoses of actual future events and developments. The company is neither responsible nor liable for these forward-looking statements. It is not responsible for updating such information, which only represents the state of affairs on the day of publication.

back to the overview